Please Wait
Applying Filters...
menu
    • menu
    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Seltorexant

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 15,938Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1293281-49-8, Jnj-42847922, [2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone, Min-202, Seltorexant [usan], (5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)(2-fluoro-6-(2h-1,2,3-triazol-2-yl)phenyl)methanone
    Molecular Formula
    C21H22FN7O
    Molecular Weight
    407.4  g/mol
    InChI Key
    SQOCEMCKYDVLMM-UHFFFAOYSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone
    2.1.2 InChI
    InChI=1S/C21H22FN7O/c1-13-8-14(2)26-21(25-13)28-11-15-9-27(10-16(15)12-28)20(30)19-17(22)4-3-5-18(19)29-23-6-7-24-29/h3-8,15-16H,9-12H2,1-2H3
    2.1.3 InChI Key
    SQOCEMCKYDVLMM-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=CC(=NC(=N1)N2CC3CN(CC3C2)C(=O)C4=C(C=CC=C4F)N5N=CC=N5)C
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. ((3ar,6as)-5-(4,6-dimethyl-2-pyrimidinyl)hexahydropyrrolo(3,4-c)pyrrol-2(1h)-yl)(2-fluoro-6-(2h-1,2,3-triazol-2-yl)phenyl)methanone

    2. Jnj-42847922

    3. Methanone, ((3ar,6as)-5-(4,6-dimethyl-2-pyrimidinyl)hexahydropyrrolo(3,4-c)pyrrol-2(1h)-yl)(2-fluoro-6-(2h-1,2,3-triazol-2-yl)phenyl)-

    4. Min-202

    2.2.2 Depositor-Supplied Synonyms

    1. 1293281-49-8

    2. Jnj-42847922

    3. [2-(4,6-dimethylpyrimidin-2-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-[2-fluoro-6-(triazol-2-yl)phenyl]methanone

    4. Min-202

    5. Seltorexant [usan]

    6. (5-(4,6-dimethylpyrimidin-2-yl)hexahydropyrrolo[3,4-c]pyrrol-2(1h)-yl)(2-fluoro-6-(2h-1,2,3-triazol-2-yl)phenyl)methanone

    7. Seltorexant (usan/inn)

    8. Gtpl9308

    9. Schembl1671257

    10. Chembl3597971

    11. Jnj-922

    12. Bdbm118454

    13. Ex-a4759

    14. Sb19652

    15. Jnj42847922

    16. Ac-36998

    17. Hy-109012

    18. Cs-0030510

    19. D11269

    20. E77321

    21. Jnj-42847922jnj-42847922

    22. Us8653263, 107

    23. ((3ar,6as)-5-(4,6-dimethylpyrimidin- 2-yl)hexahydropyrrolo(3,4-c)pyrrol-2(1h)-yl)(2-fluoro- 6-(2h-1,2,3-triazol-2-yl)phenyl)methanone

    24. [5-(4,6-dimethyl-pyrimidin-2-yl)-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone

    2.3 Create Date
    2012-11-30
    3 Chemical and Physical Properties
    Molecular Weight 407.4 g/mol
    Molecular Formula C21H22FN7O
    XLogP32.8
    Hydrogen Bond Donor Count0
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count3
    Exact Mass407.18698651 g/mol
    Monoisotopic Mass407.18698651 g/mol
    Topological Polar Surface Area80 Ų
    Heavy Atom Count30
    Formal Charge0
    Complexity609
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count2
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of major depressive disorder

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.